Form 8-K - Current report:
SEC Accession No. 0001213900-18-007187
Filing Date
2018-06-04
Accepted
2018-06-04 15:37:39
Documents
2
Period of Report
2018-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k053118_immudyneinc.htm 8-K 21119
2 LETTER OF RESIGNATION FROM RYAN ALDRIDGE f8k053118ex17-1_immudyne.htm EX-17.1 2515
  Complete submission text file 0001213900-18-007187.txt   24903
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55857 | Film No.: 18877991
SIC: 2833 Medicinal Chemicals & Botanical Products